Publicaciones en las que colabora con CELSO ARANGO LÓPEZ (21)

2023

  1. Analysis of common genetic variation across targets of microRNAs dysregulated both in ASD and epilepsy reveals negative correlation

    Frontiers in Genetics, Vol. 14

  2. Neighborhood Vulnerability and Disability in First Episode of Psychosis: A Multilevel Study

    The Journal of clinical psychiatry, Vol. 84, Núm. 2

  3. Oxytocin Exposure in Labor and its Relationship with Cognitive Impairment and the Genetic Architecture of Autism

    Journal of Autism and Developmental Disorders, Vol. 53, Núm. 1, pp. 66-79

  4. Recent natural selection conferred protection against schizophrenia by non-antagonistic pleiotropy

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Polygenic contribution to the relationship of loneliness and social isolation with schizophrenia

    Nature Communications, Vol. 13, Núm. 1

  2. The relationship between negative symptoms, social cognition, and social functioning in patients with first episode psychosis

    Journal of Psychiatric Research, Vol. 155, pp. 171-179

2021

  1. A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders

    European Neuropsychopharmacology, Vol. 48, pp. 49-88

  2. How does neighbourhood socio-economic status affect the interrelationships between functioning dimensions in first episode of psychosis? A network analysis approach

    Health and Place, Vol. 69

  3. Omega-3 fatty acids during adolescence prevent schizophrenia-related behavioural deficits: Neurophysiological evidences from the prenatal viral infection with PolyI:C

    European Neuropsychopharmacology, Vol. 46, pp. 14-27

  4. The interplay between functioning problems and symptoms in first episode of psychosis: An approach from network analysis

    Journal of Psychiatric Research, Vol. 136, pp. 265-273

2019

  1. CIBERSAM: Ten years of collaborative translational research in mental disorders

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8

  2. Oxidative stress and inflammation in first-episode psychosis: A Systematic Review and Meta-analysis

    Schizophrenia Bulletin, Vol. 45, Núm. 4, pp. 742-751

  3. Risperidone administered during adolescence induced metabolic, anatomical and inflammatory/oxidative changes in adult brain: A PET and MRI study in the maternal immune stimulation animal model

    European Neuropsychopharmacology, Vol. 29, Núm. 7, pp. 880-896

2015

  1. Desarrollo profesional en investigación traslacional en neurociencias y salud mental: educación y formación dentro del Centro de Investigación Biomédica en Red en Salud Mental

    Revista de Psiquiatria y Salud Mental, Vol. 8, Núm. 2, pp. 65-74

  2. Inflammation in schizophrenia: A question of balance

    Neuroscience and Biobehavioral Reviews, Vol. 55, pp. 612-626

2014

  1. Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study

    Schizophrenia Research, Vol. 156, Núm. 1, pp. 23-29

2013

  1. Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation

    International Journal of Neuropsychopharmacology, Vol. 16, Núm. 1, pp. 121-135

2012

  1. Antioxidant defense system and family environment in adolescents with family history of psychosis

    BMC Psychiatry, Vol. 12

  2. Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study

    Schizophrenia Research, Vol. 137, Núm. 1-3, pp. 58-65

  3. Plasma antioxidant capacity is reduced in Asperger syndrome

    Journal of Psychiatric Research, Vol. 46, Núm. 3, pp. 394-401